Barbuzza Alejo Ramiro, Ballarini Fabricio, Goyeneche Celina, Reppucci Victoria, Benedetti Pedro, Moscato Franco, Medina Jorge H, Katche Cynthia, Moncada Diego, Viola Haydeé
Department of Life Sciences, Technological Institute of Buenos Aires (ITBA), Autonomous City of Buenos Aires, ARG.
Faculty of Medicine, Universidad de Buenos Aires-Consejo Nacional de Investigaciones Científicas y Técnicas (UBA/CONICET), Institute of Cell Biology and Neuroscience "Prof. E. De Robertis" (IBCN), Autonomous City of Buenos Aires, ARG.
Cureus. 2024 Feb 26;16(2):e54932. doi: 10.7759/cureus.54932. eCollection 2024 Feb.
Background and objectives A controversy regarding the duration of generalized anxiety disorders (GAD) and depressive symptoms during the COVID-19 pandemic arose, stating that these symptoms last a short time, perhaps a few months, or that they are more persistent over time. After more than three years of the pandemic, this is still a question that requires an answer. The main goal of this work was to record the levels of self-perceived GAD and depression in the Argentine population at several time points during the pandemic to characterize whether they were transient or persisted over the successive waves of contagion. Furthermore, we studied the association between anti-COVID-19 vaccination and the high frequency of physical activity with GAD and depression levels to evaluate a possible protective role of these factors on mental health. Methods We used a descriptive and correlational research design. We carried out a repeated cross-sectional study performing seven online surveys (collection period: four to 15 days) at different time points in October 2020, May, August, October, and December 2021, and February and April 2022. The participants (24,308) were recruited through Instagram campaigns performed by renowned local scientific communicators and responded to the survey through Google Forms (Google, Mountain View, CA). Generalized anxiety was assessed using the Generalized Anxiety Disorder-7 (GAD-7). Depression was assessed using the Patient Health Questionnaire (PHQ-9). The respondents reported their symptoms using a four-point Likert scale, which led us to calculate the scores and also the prevalence (% of the population with moderate to severe symptoms) for GAD and depression and the frequency they performed physical activity per week. Data were statistically analyzed using the unpaired Mann-Whitney U-test, chi-squared, Spearman correlation, or Tukey's post hoc test after two-way ANOVA. Results Our results show that the highest prevalence for GAD and depression correspond to those of the second wave of infections (May 2021: 57.3% and 54.19%, respectively) and that the lower levels were reported by the end of the third wave (April 2022: 43.21% and 43.65%, respectively). Such levels were even lower than those reported during the first wave at the beginning of our study (October 2020: 45.94% and 48.92%, respectively). In other words, even though the third wave tripled the number of people infected with respect to the second one, its effects on mental health were attenuated. The increment in the vaccine doses inoculated between the last two waves of contagion was associated with a decrease in the GAD score (mean ± SEM: 10.75 ± 0.06 vs. 8.88 ± 0.13) and the depressive symptoms (mean ± SEM: 10.76 ± 0.07 vs. 9.23 ± 0.14). Throughout the entire study period, the fraction of the population that practiced physical activity three or more times per week was self-perceived with lower levels of GAD and depression than those who exercised less frequently. Conclusions Of the three waves of contagion that the Argentine population suffered, the highest rates of GAD and depression were recorded in the second wave, and these symptoms decreased over the months, even during the third wave, which presented the highest number of infections. Our results also suggest that the progress of the vaccination campaign and the practice of physical exercises with high frequency could play a protective role in the mental health of the population during COVID-19.
关于新冠疫情期间广泛性焦虑症(GAD)和抑郁症状的持续时间出现了争议,一种观点认为这些症状持续时间较短,可能几个月,另一种观点则认为随着时间推移它们更具持续性。在疫情持续三年多之后,这仍是一个需要解答的问题。这项工作的主要目标是记录阿根廷人群在疫情期间几个时间点的自我感知的广泛性焦虑症和抑郁症水平,以确定这些症状是短暂的还是在后续的感染浪潮中持续存在。此外,我们研究了新冠疫苗接种以及高频率体育活动与广泛性焦虑症和抑郁症水平之间的关联,以评估这些因素对心理健康可能的保护作用。
我们采用了描述性和相关性研究设计。在2020年10月、2021年5月、8月、10月和12月以及2022年2月和4月的不同时间点进行了七次在线调查(收集期:4至15天),开展了一项重复横断面研究。参与者(24308人)通过当地知名科学传播者在Instagram上开展的活动招募,并通过谷歌表单(谷歌,加利福尼亚州山景城)回复调查。使用广泛性焦虑症量表(GAD - 7)评估广泛性焦虑。使用患者健康问卷(PHQ - 9)评估抑郁症。受访者使用四点李克特量表报告他们的症状,这使我们能够计算得分以及广泛性焦虑症和抑郁症的患病率(中度至重度症状人群的百分比)以及他们每周进行体育活动的频率。在双向方差分析后,使用非配对曼 - 惠特尼U检验、卡方检验、斯皮尔曼相关性检验或图基事后检验对数据进行统计分析。
我们的结果表明,广泛性焦虑症和抑郁症的最高患病率对应于第二波感染(2021年5月:分别为57.3%和54.19%),而在第三波结束时报告的水平较低(2022年4月:分别为43.21%和43.65%)。这些水平甚至低于我们研究开始时第一波期间报告的水平(2020年10月:分别为45.94%和48.92%)。换句话说,尽管第三波感染人数相对于第二波增加了两倍,但其对心理健康的影响有所减弱。最后两波感染期间接种疫苗剂量的增加与广泛性焦虑症得分的降低(均值±标准误:10.75±0.06 vs. 8.88±0.13)和抑郁症状的降低(均值±标准误:10.76±0.07 vs. 9.23±0.14)相关。在整个研究期间,每周进行三次或更多次体育活动的人群自我感知的广泛性焦虑症和抑郁症水平低于那些锻炼频率较低的人群。
在阿根廷人群经历的三波感染中,第二波记录到的广泛性焦虑症和抑郁症发病率最高,并且这些症状在几个月内有所下降,即使在感染人数最多的第三波期间也是如此。我们的结果还表明,疫苗接种运动的进展以及高频率体育锻炼的开展可能在新冠疫情期间对人群的心理健康起到保护作用。